Fingerprick COVID-19 antibody test put to the test

NCT ID NCT04597047

Completed Diagnosis Sponsor: LumiraDx UK Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checks whether a fingerstick blood test for COVID-19 antibodies gives the same results as standard lab tests using blood from a vein. About 42 people who recently had a positive COVID-19 PCR test will provide both fingerstick and venous blood samples. The goal is to see if the quick, easy fingerstick method is accurate enough for use at point-of-care sites like doctor's offices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If accurate, this fingerstick test could make COVID-19 antibody testing faster and easier at clinics and pharmacies.
What could go wrong: This is a small study (42 people) focused on test accuracy, not treatment. The test may not perform as well in larger, real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID19

Contacts and locations

Locations

Centura Health Physician Group, Northglenn Office

Northglenn, Colorado, 80234, United States
Eclipse Clinical Research

Tucson, Arizona, 85745, United States
Physicians Quality Care of Jackson

Jackson, Tennessee, 38305, United States
Professional Research Network of Kansas

Wichita, Kansas, 67203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.